Alzheimer’s disease researchers reported a molecular mechanism that regulates amyloid plaque formation by controlling BACE1 through the protein FBXW7α. The study, published in Cell Death Discovery by authors including Yang Y., Jia L., and Xu J., links the FBXW7α pathway to downstream APP processing relevant to plaque pathology. The update adds to the growing set of intracellular or pathway-regulation approaches to amyloid biology beyond traditional beta-secretase inhibition strategies. By mapping an upstream control point for BACE1 formation and activity, the work suggests new intervention locations. In separate neurodegeneration progress, a different report focused on fragility in disease-relevant targets, though the Alzheimer’s-specific mechanistic update is the direct pipeline-relevant item for therapeutic translation. Overall, the mechanism-centric framing signals continued interest in identifying “switch” proteins that govern amyloidogenic processing steps, which can expand medicinal chemistry opportunity space.